Page 28 - FBL AR 2019-20

Fermenta Biotech Limited
Annual Report 2019-20

COVID-19

preparedness and response

Ensuring business continuity in the new normal

In the light of the gravity of the COVID-19 crisis, pace and unprecedented disruption, Fermenta
remained committed to all its stakeholders. The Company took proactive measures to minimise
disruptions to operations while prioritising the health of its employees. Your Company is engaged in a
continuous endeavour to rebound from the impact of the pandemic.

Respond Recover Rebound

Your Company mobilised a In these unparalleled times, the Fermenta believes that the post-
taskforce to monitor the situation Indian government classified COVID-19 scenario will be a
in real-time and leverage business our operations as ‘essential’ for completely different workplace and
continuity plans in accordance maintaining the health and put in place measures to adapt to
with the dynamic realities. The immunity of communities this change. As the world prepares
taskforce ensured the creation of worldwide. Even as we continued for the new normal, Fermenta took
a robust implementable business to manufacture products, Fermenta precautions to ensure the safety of
continuity plan that was put into remained committed to the stakeholders, even as it continued
immediate action to mitigate the safety, health and well-being of to monitor the situation in real-time
impact of COVID-19 on its business. its various teams. The Company for updates. Fermenta put into place
Even as Fermenta was one of the took appropriate precautions and strategic measures to mitigate risks
first companies in its location to implemented safeguards to protect to business operations as well as
implement remote working, the employees while they continued to human capital protection.
prudent utilisation of technology address global product needs.
ensured that employees remained
digitally connected with minimal
operational disruption.

26